Published: May 21, 2026
Written by Klarity Editorial Team
Published: May 21, 2026

The landscape of mental health telehealth has transformed dramatically over the past few years. What began as a COVID-era convenience has evolved into a complex ecosystem of providers—some thriving, others facing regulatory scrutiny, and a few that have disappeared entirely. If you’re considering online mental health care in 2026, understanding your options has never been more important.
Whether you’re seeking treatment for anxiety, depression, ADHD, insomnia, or other conditions, this comprehensive guide breaks down the current state of telehealth mental health services, comparing major providers on availability, medication policies, pricing, and quality of care.
The telehealth mental health industry has matured considerably since the pandemic boom. Early providers that prioritized rapid growth over quality care have largely exited the market—some through shutdown, others through legal action. What remains is a more regulated, patient-focused industry where trust and clinical integrity matter more than ever.
Not all telehealth mental health providers that launched during the pandemic have survived. Done, once a leading ADHD-focused telehealth platform, faced federal prosecution in 2024 when top executives were criminally charged for inappropriate prescribing practices. The company effectively ceased operations, leaving thousands of patients scrambling for alternative care.
Ahead, another ADHD-focused startup, shut down in 2022 due to operational and financial challenges. These closures highlight an important reality: convenience alone isn’t enough. Patients increasingly demand both accessibility and clinical legitimacy.
Meanwhile, Cerebral—once one of the fastest-growing mental health startups—dramatically scaled back services after regulatory scrutiny. In May 2022, Cerebral stopped prescribing all new ADHD stimulant medications and paid $3.6 million in fines to settle compliance violations. The company still operates but with significantly more conservative prescribing policies.
Talkiatry represents the gold standard for comprehensive psychiatric care via telehealth. Unlike many competitors, Talkiatry employs board-certified psychiatrists who can diagnose and treat the full spectrum of mental health conditions, including prescribing controlled medications when clinically appropriate.
What Talkiatry Offers:
The Trade-off: While Talkiatry provides comprehensive care, wait times can extend to 1-3 weeks for initial appointments in high-demand areas. Insurance billing, while helpful for cost, can sometimes result in surprise charges or complications when switching providers.
Brightside focuses exclusively on depression, anxiety, PTSD, OCD, and insomnia. The platform distinguishes itself through a strict ‘no controlled substances’ policy, which shapes both its strengths and limitations.
What Brightside Offers:
What Brightside Won’t Do:
Brightside works well for individuals seeking treatment for depression or anxiety who prefer to avoid controlled medications entirely. However, if you have ADHD or require medications outside their approved list, you’ll need to look elsewhere.
The major general telehealth platforms—Teladoc, MDLive, and Amwell—offer mental health services as part of broader medical care. These platforms treat everything from sinus infections to anxiety, often at no cost to patients whose employers or insurers include telehealth benefits.
What These Platforms Offer:
Significant Limitations:These platforms explicitly prohibit prescribing:
Pricing for self-pay:
These services work best for straightforward cases of mild anxiety or depression, or when patients need general medical care alongside basic mental health support. For specialized psychiatric needs, especially involving controlled medications, they fall short.
PlushCare bridges primary care and mental health, offering a broader scope than pure urgent care but less psychiatric specialization than platforms like Talkiatry.
What PlushCare Offers:
What PlushCare Won’t Prescribe:
PlushCare serves patients who want comprehensive primary care alongside mental health support, particularly those interested in weight management through newer GLP-1 medications. However, like other general platforms, it cannot address ADHD or conditions requiring controlled substances.
Hims & Hers has expanded from its original men’s and women’s health focus (hair loss, erectile dysfunction, skincare) into mental health and weight management.
What Hims & Hers Offers:
What Hims & Hers Won’t Do:
Hims & Hers appeals to patients seeking a lifestyle-oriented approach to wellness, combining mental health support with other health concerns. The straightforward pricing and lack of insurance hassles attract many users, though the inability to prescribe controlled medications limits its scope.
Cerebral continues to operate but bears the scars of its rapid-growth era. After stopping all new ADHD stimulant prescriptions in May 2022 and settling federal compliance violations for $3.6 million, Cerebral now takes a markedly conservative approach.
Current Cerebral Services:
What Cerebral No Longer Offers:
Patient reviews of Cerebral post-2022 are mixed, with common complaints including provider turnover, difficulty reaching prescribers, and frustration over the subscription model that charges monthly regardless of whether appointments occur.
One of the most significant differences among telehealth providers lies in prescribing policies, particularly regarding controlled substances. Recent regulatory scrutiny has created a bifurcated market: specialized psychiatric platforms that can prescribe controlled medications responsibly, and everyone else who simply won’t.
Who prescribes stimulants: Only full-service psychiatric telehealth platforms like Talkiatry routinely prescribe ADHD stimulants (Adderall, Vyvanse, Ritalin, Concerta) when clinically appropriate. These platforms employ psychiatrists or psychiatric nurse practitioners who conduct thorough evaluations before prescribing.
Who doesn’t: Essentially everyone else. Brightside, PlushCare, Teladoc, MDLive, Amwell, Hims & Hers, and the current iteration of Cerebral all prohibit ADHD stimulant prescriptions. Done and Ahead, which did prescribe stimulants, are no longer operating.
The regulatory context: The Ryan Haight Act typically requires an in-person medical evaluation before prescribing controlled substances. COVID-era waivers allowed tele-prescribing, and these waivers were extended through the end of 2025. However, uncertainty remains about 2026 and beyond. The federal prosecution of Done’s executives for allegedly inappropriate ADHD prescribing sent shockwaves through the industry, making many providers extremely cautious or entirely unwilling to prescribe stimulants via telehealth.
Who prescribes benzodiazepines: Very few telehealth platforms will prescribe Xanax, Ativan, Klonopin, or other benzodiazepines. Talkiatry’s psychiatrists may prescribe them when medically necessary, but even they use them conservatively given addiction risks.
Who doesn’t: Brightside, Cerebral, PlushCare, Teladoc, MDLive, Amwell, and Hims & Hers all explicitly prohibit benzodiazepine prescriptions. For anxiety, these platforms rely on SSRIs, SNRIs, buspirone, hydroxyzine, and other non-controlled alternatives.
The clinical rationale: Beyond regulatory caution, there’s legitimate clinical reason for this approach. Benzodiazepines carry significant addiction risk and aren’t recommended as first-line anxiety treatment by most guidelines. Platforms avoiding them aren’t necessarily being overly restrictive—they’re following evidence-based practice.
Who prescribes sleep medications: Again, very few platforms. Talkiatry’s providers may prescribe Ambien, Lunesta, or similar medications in select cases.
Who doesn’t: Brightside, Cerebral, Teladoc, Amwell, and PlushCare all prohibit tele-prescribing of controlled sleep medications.
Alternatives offered: Most platforms treating insomnia rely on trazodone (an off-label use of an antidepressant), melatonin agonists like ramelteon, antihistamines, or cognitive behavioral therapy for insomnia (CBT-I). These approaches often work well and avoid the tolerance and dependence issues of traditional sleep medications.
The GLP-1 revolution has created an unexpected divide in telehealth. Medications like Wegovy and Ozempic (semaglutide) and Saxenda (liraglutide) aren’t DEA-controlled substances, opening them to broader telehealth prescribing.
Who prescribes GLP-1s: Hims & Hers launched a prominent weight loss program in 2023 featuring GLP-1 prescriptions. PlushCare will prescribe them for appropriate patients (obesity with comorbidities). Some traditional providers like MDLive may prescribe them for diabetes management.
Who doesn’t: Mental health-focused platforms (Brightside, Cerebral, Talkiatry) don’t address weight loss. Teladoc explicitly excludes GLP-1 weight medications from its general telehealth prescribing.
The controversy: In 2025, the FDA issued warning letters to several telehealth companies, including Hims & Hers, for marketing compounded semaglutide—non-FDA-approved versions made by compounding pharmacies. This regulatory action highlights ongoing scrutiny of telehealth weight loss services.
Most major telehealth platforms now operate nationwide or near-nationwide, but licensing requirements create some variations:
Nationwide (all 50 states):
Multi-state (40+ states):
No longer operating:
For the six most populous states (California, Texas, Florida, New York, Pennsylvania, Illinois), every active major provider operates in all of them. Geographic access is generally no longer a barrier for telehealth mental health services—the limitations lie in what conditions providers treat and what medications they’ll prescribe.
Telehealth mental health pricing varies dramatically by provider, insurance status, and service model.
Cerebral:
Brightside:
Hims & Hers:
Pros of subscriptions: Predictable monthly cost; includes messaging with providers between visits; can feel simpler than per-visit billing.
Cons: You pay every month regardless of whether you need an appointment; can be expensive if you only need occasional check-ins; difficult to pause or cancel with some providers.
Talkiatry (without insurance):
PlushCare:
Teladoc:
MDLive:
Amwell:
Pros of per-visit: Pay only when you need care; potentially lower total cost if you need infrequent visits; easier to stop or pause.
Cons: Less predictable monthly expense; some patients benefit from the accountability of a subscription model.
Insurance dramatically changes the cost equation. If your employer includes telehealth benefits through Teladoc or MDLive, you might pay nothing for visits. Talkiatry, Brightside, and PlushCare increasingly accept major insurance plans, with typical co-pays ranging from $0-$75 per visit.
The insurance trade-offs:
Cash-pay services like Hims & Hers avoid insurance complexities entirely but don’t help with deductibles. HSA and FSA funds typically cover these services, providing some tax advantage.
As you evaluate these options, it’s worth considering what gaps exist in the current market—gaps that newer, patient-focused platforms like Klarity Health are designed to fill.
Many patients find themselves in a frustrating middle ground. General platforms like Teladoc won’t treat their ADHD or prescribe necessary controlled medications. Specialized psychiatric platforms like Talkiatry can help but may have multi-week wait times and insurance complexities. The startup platforms that once filled this gap (Done, Ahead) have exited amid controversy.
Klarity addresses this by combining psychiatric specialization with rapid access. Board-certified providers can evaluate and treat the full spectrum of mental health conditions, including ADHD, within days rather than weeks—and they’re willing to prescribe controlled medications responsibly when clinically appropriate.
Subscription models that charge monthly regardless of visit frequency frustrate many patients, as do the unexpected bills that sometimes arise with insurance-based care. Klarity uses straightforward, per-visit pricing (initial evaluation, follow-up visit, medication refill request), so you pay only for services you actually receive. For many patients, this à la carte approach costs less than monthly subscriptions, especially if you reach stability and need only occasional check-ins.
After the Done prosecution and Cerebral settlement, patients rightfully question whether online mental health providers are legitimate. Are they pill mills, or do they provide real care?
Klarity emphasizes the middle ground: neither reflexively refusing controlled medications (like Brightside or Teladoc) nor rubber-stamping prescriptions without proper evaluation (like Done allegedly did). Every patient receives a thorough initial assessment. Providers prescribe what’s clinically appropriate—whether that’s therapy alone, non-controlled medication, or controlled medication with proper monitoring. This individualized approach builds trust while ensuring access to effective treatment.
Provider turnover plagues some subscription platforms, forcing patients to re-establish relationships with new clinicians every few months. Insurance-based platforms may require switching providers if network status changes. Klarity prioritizes continuity—once you match with a provider, they remain your provider for ongoing care, building the kind of therapeutic relationship that leads to better outcomes.
Klarity accepts both insurance and self-pay, giving patients flexibility. If you have good coverage, use it. If you’re uninsured, face high deductibles, or simply prefer predictable out-of-pocket costs, pay cash at rates often lower than competitors’ subscription fees. This dual approach serves the broadest possible patient base.
Choosing a telehealth mental health provider requires matching your specific needs with what each platform offers. Consider these questions:
1. What conditions do you need treated?
2. Do you need controlled medications?
3. How important is rapid access?
4. What’s your insurance situation?
5. What’s your budget?
6. Do you have other health concerns?
The telehealth mental health landscape of 2026 is vastly different from the Wild West days of 2020-2021. Regulatory oversight, market consolidation, and patient demand for legitimacy have transformed the industry. What remains is a diverse ecosystem where different platforms serve different needs.
For straightforward depression or anxiety without controlled medications, services like Brightside or insurance-covered general telehealth work well. For comprehensive psychiatric care including ADHD and complex conditions, specialized platforms like Talkiatry or Klarity provide the clinical depth required. For lifestyle-oriented wellness combining mental health with other concerns, Hims & Hers offers an appealing package.
The key is matching your specific situation—your conditions, medication needs, insurance status, budget, and preferences—with a provider genuinely equipped to help. Don’t assume all telehealth is the same, and don’t settle for a platform that can’t address your actual needs.
If you’re struggling with ADHD, anxiety, depression, insomnia, or other mental health concerns and haven’t found the right provider, Klarity Health offers a different approach: board-certified psychiatric providers who see you quickly, prescribe what’s clinically appropriate (including controlled medications when needed), and charge transparent prices whether you use insurance or pay cash.
Klarity’s providers are available in most states, typically offer appointments within days, and focus on building ongoing relationships rather than churning through patients. Initial evaluations provide comprehensive assessment of your condition and treatment options. Follow-up care ensures your treatment plan works and adjusts it when needed.
Visit Klarity Health to book an appointment and experience the balance of access, quality, and affordability that today’s mental health care should provide.
Can I get Adderall or other ADHD medications through telehealth?
Yes, but only through specialized psychiatric telehealth platforms. Services like Talkiatry and Klarity employ board-certified psychiatrists or psychiatric nurse practitioners who can prescribe ADHD stimulants after proper evaluation. General telehealth platforms (Teladoc, MDLive, PlushCare, Amwell) and most mental health-specific subscriptions (Brightside, Hims, current Cerebral) do not prescribe ADHD stimulants.
Why won’t most telehealth providers prescribe controlled medications?
Multiple factors drive this: regulatory caution following the Done prosecution and Cerebral settlement; uncertainty about post-2025 changes to the Ryan Haight Act waiver; liability concerns; and difficulty conducting thorough evaluations remotely. Providers that do prescribe controlled medications invest heavily in compliance programs, thorough evaluations, and ongoing monitoring.
Is telehealth mental health care as good as in-person care?
For many conditions and patients, yes. Research shows telehealth delivers comparable outcomes to in-person care for depression, anxiety, and ADHD management. Video visits allow providers to observe patients, assess symptoms, and build therapeutic relationships effectively. However, some complex situations benefit from in-person evaluation, and certain therapeutic modalities work better face-to-face.
How long does it take to get an appointment?
This varies dramatically:
What if I need to switch providers?
With subscription services, switching can be complicated—you may need to cancel and restart elsewhere, potentially losing access to your current prescriptions during transition. With per-visit services like Klarity, you can more easily try different providers or switch to in-person care since you’re not locked into a subscription. When possible, ensure you have a plan to continue your medications during any provider transition.
Will my insurance cover telehealth mental health services?
Increasingly, yes. Most major insurers now cover telehealth mental health at the same rate as in-person care. Talkiatry, Brightside, PlushCare, and Klarity all accept various insurance plans. General platforms like Teladoc, MDLive, and Amwell often come free through employers. Check with your specific plan about telehealth mental health benefits and whether your chosen provider is in-network.
Associated Press. ‘DOJ indicts Done Global executives for ADHD telehealth prescribing violations.’ June 14, 2024. apnews.com
TIME Magazine. ‘Why Online Therapy Startups Are Falling Short.’ November 1, 2022. time.com
TechTarget Healthcare IT News. ‘Pushing ADHD telehealth prescriptions costs Cerebral millions.’ November 6, 2024. techtarget.com
Associated Press. ‘FDA launches crackdown on telehealth weight-loss medication marketing.’ September 16, 2025. apnews.com
FinVsFin. ‘Hims Anxiety and Mental Health Reviews: Cost and Services Guide.’ December 9, 2025. finvsfin.com
📅 Research Currency Statement
Verified as of: January 4, 2026
Providers verified active: Cerebral, Brightside, Talkiatry, PlushCare, MDLive, Teladoc, Amwell, Hims/Hers
Providers with uncertain status: Done (federal prosecution; operations ceased), Ahead (shut down 2022)
Key sources: DOJ press releases 2024; industry news (TechTarget, TIME, AP); official provider policies (Teladoc, PlushCare, Brightside); competitor reviews and recent analyses 2025
Find the right provider for your needs — select your state to find expert care near you.